| Literature DB >> 27524942 |
Marta Pokrywczynska1, Daria Balcerczyk1, Arkadiusz Jundzill1, Maciej Gagat2, Monika Czapiewska1, Tomasz Kloskowski1, Maciej Nowacki3, Agata M Gastecka1, Magdalena Bodnar4, Alina Grzanka2, Andrzej Marszalek5, Tomasz Drewa6.
Abstract
BACKGROUND: A key requirements for therapy utilizing the tissue engineering methodologies is use of techniques which have the capability to yield a high number of cells, from small tissue biopsy in a relatively short time. Up to date there was no optimal methods of isolation and expansion of urinary bladder smooth muscle cells (UB-SMCs). The aim of this study was to compare isolation and expansion techniques of UB-SMCs to select the most repeatable and efficient one.Entities:
Keywords: Isolation; Primary culture; Smooth muscle cells; Tissue engineering
Year: 2016 PMID: 27524942 PMCID: PMC4982216 DOI: 10.1186/s12575-016-0047-9
Source DB: PubMed Journal: Biol Proced Online ISSN: 1480-9222 Impact factor: 3.244
Fig. 1Preparation of the fragments of smooth muscle layer for isolation of urinary bladder smooth muscle cells (a-f)
Protocols used for establishment of urinary bladder smooth muscle cells culture
| Method | Source article | Modified element | Originally | After modification |
|---|---|---|---|---|
| I | McCoy 2013 [ | Tissue source | Human | Pig |
| Quantity of the tissue | 1g | 1 cm2 | ||
| Digestion solution | Collagenase IV (450U/ml), Dispase II, CaCl2 5mM | Collagenase II (0.15%, 275U/mg), Dispase II (0.2%, 175U/mg), CaCl2 5mM, HBSSa | ||
| Volume of the digestion solution | 40ml | 5ml | ||
| Digestion conditions | 1h, 37°C | 1.5h, 37°C | ||
| Seeding density | All cells/300–350cm2 | 20 000 cells/cm2 | ||
| Growth media | DMEM High glucoseb, FBSc (10%), Gentamycin (5μg/ml) | A: DMEM High glucoseb, FBSc Pan-Biotech (10%), Gentamycin (100μg/ml), Amphotericin B (5μg/ml), Penicillin (100U/ml), Streptomycin (100μg/ml) | ||
| B: DMEM High glucoseb, FBSc Sigma (10%), Gentamycin (100μg/ml), Amphotericin B (5μg/ml), Penicillin (100U/ml), Streptomycin (100μg/ml) | ||||
| C: SmGM-2 | ||||
| II | Cheng et al. 2011 [ | Tissue source | Pig | Pig |
| Quantity of the tissue | No data | 1 cm2 | ||
| Digestion solution | Trypsin-EDTA (0,25%) | Trypsin (0.25%), EDTA (0.02%), Collagenase II (0.15%, 275U/mg), CaCl2 5mM | ||
| Volume of the digestion solution | No data | 5ml | ||
| Digestion conditions | 30min., 37°C | 1h, 37°C | ||
| Seeding density | 106 cells/well (48-well plate) | 20 000 cells/cm2 | ||
| Growth media | RPMI 1640d, FBSc (10%) | A, B, C | ||
| III | Lau et al. 1996 [ | Tissue source | Rabbit | Pig |
| Quantity of the tissue | Whole urinary bladder muscle layer | 1 cm2 | ||
| Digestion solution | Collagenase I (0.1%), SFNMe | Collagenase II (0.1%, 275U/mg), CaCl2 5mM, DMEM High glucoseb | ||
| Volume of the digestion solution | 20ml | 5ml | ||
| Digestion conditions | ~16h, 37°C | ~16h, 37°C | ||
| Seeding density | 105 cells/35mm culture dish | 20 000 cells/cm2 | ||
| Growth media | SFNMe
| A, B, C | ||
| IV | Ma et al. 2002 [ | Tissue source | Rat | Pig |
| Quantity of the tissue | Whole urinary bladder muscle layer | 1 cm2 | ||
| Digestion solution | 1. trypsin (0.2%) | 1. trypsin (0.2%) | ||
| Volume of the digestion solution | No data | 5ml | ||
| Digestion conditions | 1. 30min., 37°C | 1. 30min., 37°C | ||
| Seeding density | No data | 20 000 cells/cm2 | ||
| Growth media | RPMI 1640d, FCS (10%) | A, B, C | ||
| V | McCoy 2013 [ | Tissue source | Human | Pig |
| Number of explants | 20–25 tissue explants (1mm diameter) | explants from 1 cm2 of tissue (1mm diameter) | ||
| Culture dish | 100 mm tissue culture Petri dish | 60 mm tissue culture Petri dish | ||
| Growth media | DMEM High glucoseb, FBSc (10%), Gentamicin (5μg/ml) | A, B, C |
a HBSS Hank’s Balanced Salt Solution
b DMEM High glucose Dulbecco’s Modified Eagle Medium with high glucose
c FBS Fetal Bovine Serum
d RPMI 1640 Roswell Park Memorial Institute medium 1640
e SFNM Serum-Free Nutrient Medium
Fig. 2Histological and immunohistochemical staining of the bladder wall before (a,b,e,f,i,j) and after surgical removal of the mucosa/submucosa and serosa (c,d,g,h,k,l): hematoxylin and eosin (HE) staining (a,b,c,d), anti- α-smooth muscle actin (α-SMA) staining (e,f,g,h) and anti- p63 protein (p63) staining (i,j,k,l). Light microscope, objective magnification x4; bar 400μm
Fig. 3Number of cells isolated from 1 cm2 of urinary bladder muscle. Boxes indicate median and interqartile range with vertical lines depicting the range. I vs II p < 0.001; I vs III p = 1.00; I vs IV p < 0.001; II vs III p < 0.001; II vs IV p = 1.00; III vs IV p < 0.001
Fig. 4Bladder smooth muscle cells in the fifth day of culture. Cells isolated by methods I-V and cultured in three different media: DMEM HG with FBS Pan-Biotech (a), DMEM HG with FBS Sigma (b) and SmGM-2 (c). Inverted microscope, objective magnification x10; bar 100μm
Success rate of establishment of primary cultures of porcine urinary bladder smooth muscle cells
| Isolation method | Growth medium | Number of confluent cultures | Number of cultures with normal morphology | Success rate |
|---|---|---|---|---|
| I | A | 3/9 (33.3%) | 2/9 (22.2%) | 1/9 (11.1%) |
| B | 0/9 (0 %) | 7/9 (77.8%) | 0/9 (0 %) | |
| C | 9/9 (100%) | 9/9 (100%) | 9/9 (100%) | |
| II | A | 2/9 (22.2%) | 0/9 (0 %) | 0/9 (0 %) |
| B | 0/9 (0 %) | 0/9 (0 %) | 0/9 (0 %) | |
| C | 9/9 (100%) | 9/9 (100%) | 9/9 (100%) | |
| III | A | 3/9 (33.3%) | 1/9 (11.1%) | 1/9 (11.1%) |
| B | 0/9 (0 %) | 5/9 (55.6%) | 0/9 (0 %) | |
| C | 9/9 (100%) | 9/9 (100%) | 9/9 (100%) | |
| IV | A | 0/9 (0 %) | 1/9 (11.1%) | 0/9 (0 %) |
| B | 0/9 (0 %) | 0/9 (0 %) | 0/9 (0 %) | |
| C | 9/9 (100%) | 9/9 (100%) | 9/9(100%) | |
| V | A | 0/9 (0 %) | 0/9 (0 %) | 0/9 (0 %) |
| B | 0/9 (0 %) | 0/9 (0 %) | 0/9 (0 %) | |
| C | 0/9 (0 %) | 2/9 (22.2%) | 0/9 (0 %) |
Fig. 5Expression of α-smooth muscle actin in primary cultures of cells isolated by the methods I-IV and cultured in three different media: DMEM HG with FBS Pan-Biotech (a), DMEM HG with FBS Sigma (b) and SmGM-2 (c). Immunofluorescence staining with antibody against α-smooth muscle actin, nuclei stained with DAPI, laser scanning confocal microscopy; bar 25μm
Fig. 6Expression of smoothelin in primary cultures of cells isolated by the methods I-IV and cultured in three different media: DMEM HG with FBS Pan-Biotech (a), DMEM HG with FBS Sigma (b) and SmGM-2 (c). Immunofluorescence staining with antibody against smoothelin, nuclei stained with DAPI, laser scanning confocal microscopy; bar 25μm
Fig. 7Relative cell fluorescence (RCF) for anti- smoothelin (a) and anti-α-SMA (b) in primary cultures of cells isolated by methods I-IV and cultured in three different media (a-c). Boxes indicate median and interqartile range with vertical lines depicting the range. * p < 0.001 vs IC; ** p < 0.05 vs IC
Cell population homogeneity
| Method | α-SMA [%] | Smoothelin [%] | |
|---|---|---|---|
| I | A | 31 | 0 |
| B | 3 | 0 | |
| C | 98 | 83 | |
| II | A | 0 | 0 |
| B | 0 | 0 | |
| C | 29 | 0 | |
| III | A | 11 | 0 |
| B | 0 | 0 | |
| C | 54 | 0 | |
| IV | A | 12 | 0 |
| B | 0 | 0 | |
| C | 40 | 0 | |
Percentage of cells showing α-smooth muscle actin (α-SMA) and smoothelin filaments organization
Fig. 8Flow cytometry analysis. Cells from fourth passage exhibit 99.5% expression of α-SMA. Isotype control using IgG2a excluded unspecific binding of antibody
Fig. 9Porcine urinary bladder smooth-muscle cell growth curve plotted based on the number of cells in culture determined by trypan blue assay (a) or MTT assay (b) and measurements of impedance using the X-Celligence system; red curve - test samples (cultures of porcine bladder smooth muscle cells), green curve- control (medium SmGM-2) (c). Growth phases (log, lag, plateau) are separated by dotted lines, PDT - population doubling time
Fig. 10Analysis of cellular senescence in cultures of porcine urinary bladder smooth muscle cells from 1st to 8th passage (a-h respectively); negative control - mouse 3T3 fibroblasts (i,j); single aging cells indicated by arrows. Inverted microscope, objective magnification x10; bar 200μm